National Cancer Institute head Dr. Andrew von Eschenbach is leaving his job at the agency to concentrate on his role at the FDA. Critics have argued that it was inappropriate for von Eschenbach to hold the top jobs at both agencies given the potential conflicts of interest involved. Dr. John Niederhuber moves into the top spot at NCI. Washington observers doubt that von Eschenbach will be formally confirmed in his FDA role any time soon since Democrats have vowed to place a hold on his nomination until the agency issues a decision on the Plan B contraceptive.

- see this Washington Post article [1]